Pharmacogenetics-based therapeutic recommendations — ready for clinical practice? (Q60486854)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16056390%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

review article

1 reference

title

Pharmacogenetics-based therapeutic recommendations--ready for clinical practice? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16056390%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

Julia Kirchheiner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16056390%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Uwe Fuhr

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16056390%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Jürgen Brockmöller

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16056390%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16056390%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Drug Discovery

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16056390%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16056390%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16056390%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

639-647

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16056390%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrd1801

4 January 2020

exact match

0 references

cites work

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

1 reference

Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia

31 March 2020

1 reference

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

31 March 2020

1 reference

Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?

31 March 2020

1 reference

Technology platforms for pharmacogenomic diagnostic assays

31 March 2020

1 reference

Drug metabolism and variability among patients in drug response

31 March 2020

1 reference

Moving towards individualized medicine with pharmacogenomics

31 March 2020

1 reference

Measuring the value of pharmacogenomics

31 March 2020

1 reference

Pharmacogenetics and Pharmacogenomics in Drug Development and Regulatory Decision Making: Report of the First FDA‐PWG‐PhRMA‐DruSafe Workshop

31 March 2020

1 reference

Pharmacogenomics in Drug Development and Regulatory Decision-making: the Genomic Data Submission (GDS) Proposal

31 March 2020

1 reference

CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages

31 March 2020

1 reference

Clinical consequences of cytochrome P450 2C9 polymorphisms

31 March 2020

1 reference

The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics

31 March 2020

1 reference

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression

31 March 2020

1 reference

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

31 March 2020

1 reference

Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity

31 March 2020

1 reference

Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncology.

31 March 2020

1 reference

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

31 March 2020

1 reference

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

31 March 2020

1 reference

A new system for grading recommendations in evidence based guidelines

31 March 2020

1 reference

The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population

31 March 2020

1 reference

Venlafaxine serum levels and CYP2D6 genotype

31 March 2020

1 reference

Relative citation impact of various study designs in the health sciences

31 March 2020

1 reference

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

31 March 2020

1 reference

Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

31 March 2020

1 reference

Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites

31 March 2020

1 reference

Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment

31 March 2020

1 reference